Quickly optimizing therapy

for patients with life-threatening infections is critical. Hours count, and you've been waiting for days. You need answers...

MicroPhage provides

answers to clinicians seeking to optimize antibiotic therapy earlier in the course of disease. MicroPhage products are dedicated to improving patient outcomes, decreasing length of hospital stay and enhancing antimicrobial stewardship.

KeyPath™ Training Material & Resources

• KeyPath™ Product Demonstration Video
• KeyPath™ Test Procedure Training Video
• KeyPath™ Quality Control Training Video
• Quick Reference Guide
• Material Safety Data Sheet (MSDS)

News:

Sep 11, 2012:

• KeyPath highlighted in Medical Device Daily

July 10, 2012:

• MicroPhage enters Clinical Trials for bioMerieux Blood Culture Bottles

May, 2012:

• KeyPath in CAP Today Cover Story

April 10, 2012:

• MicroPhage KeyPath™ Test Receives Expanded Clearance

More News...

Events:

• 9/5/2012 SWACM
• 9/9/2012 ICAAC
• 9/26/2012 RMHMS
• 10/17/2012 IDWeek 2012
• 11/1/2012 SCASM
• 11/7/2012 SEACM
• 12/2/2012 ASHP

More Events...

Literature:

• Case for Accelerated Susceptibility Testing in the Era of Antibiotic Resistance
• Controlled Multicenter Evaluation of a Bacteriophage Based Method for the Rapid Detection of S. aureus in Positive BCs
• KeyPath^™ MRSA/MSSA Blood Culture Test – BT Accurately Identifies S. aureus Isolates of Broad Phylogenetic Diversity
• FDA News Release on KeyPath^™

More Literature...